{"id":24754,"date":"2026-05-11T16:40:27","date_gmt":"2026-05-11T14:40:27","guid":{"rendered":"https:\/\/www.adocia.com\/test-page\/"},"modified":"2026-06-11T12:22:19","modified_gmt":"2026-06-11T10:22:19","slug":"test-page","status":"publish","type":"page","link":"https:\/\/www.adocia.com\/fr\/test-page\/","title":{"rendered":"Test page"},"content":{"rendered":"\n        <div id=\"pipeline2\">\n            <div class=\"table\">\n                <div class=\"table-header\">\n                    <div>Programme<\/div>\n                    <div>Description<\/div>\n                    <div>Indication<\/div>\n                    <div>Pr\u00e9clinique<\/div>\n                    <div>Phase 1<\/div>\n                    <div>Phase 2<\/div>\n                    <div>Phase 3<\/div>\n                    <div>R\u00e9glementaire<\/div>\n                    <div>Commercialisation<\/div>\n                    <div>Partenaire<\/div>\n                <\/div>\n                \n<div class=\"pipeline-item\">\n    <div class=\"first_level\">\n        <div class=\"infos\">\n            <h3 class=\"title\">BioChaperone<sup>\u00ae<\/sup><br \/>\r\nLispro<\/h3>\n            <div class=\"sd\">\n                <span class=\"label\">Description :<\/span>\n                Insuline Ultra-Rapide            <\/div>\n            <div class=\"i\">\n                <span class=\"label\">Indication :<\/span>\n                Diab\u00e8te            <\/div>\n        <\/div>\n        <div class=\"cell\"><span class=\"label\">Pr\u00e9clinique<\/span><\/div>\n        <div class=\"cell\"><span class=\"label\">Phase 1<\/span><\/div>\n        <div class=\"cell\"><span class=\"label\">Phase 2<\/span><\/div>\n        <div class=\"cell\"><span class=\"label\">Phase 3<\/span><\/div>\n        <div class=\"cell\"><span class=\"label active\">R\u00e9glementaire<\/span><\/div>\n        <div class=\"cell\"><span class=\"label\">Commercialisation<\/span><\/div>\n        <div class=\"bar\">\n            <svg version=\"1.1\" class=\"pipeline_img\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" x=\"0px\" y=\"0px\"\n                 viewBox=\"0 0 1950 50\" style=\"enable-background:new 0 0 1950 80;\" xml:space=\"preserve\">\n                <rect x=\"0\" y=\"0\" width=\"1625\" height=\"100%\" rx=\"10\" ry=\"10\"><\/rect>\n            <\/svg>\n        <\/div>\n\n        <div class=\"partner\">\n                            <ul>\n                                            <li>\n                            <img loading=\"lazy\" decoding=\"async\" width=\"250\" height=\"186\" src=\"https:\/\/www.adocia.com\/composants\/uploads\/2023\/05\/logo-tonghua_dongbao.png\" class=\"attachment-full size-full\" alt=\"Tonghua Dongbao\" \/>                        <\/li>\n                                    <\/ul>\n                    <\/div>\n\n        <button type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#item-5349\" aria-expanded=\"false\" aria-controls=\"item-5349\">\n            <img decoding=\"async\" src=\"https:\/\/www.adocia.com\/composants\/themes\/adocia\/inc\/assets\/img\/icon-plus.png\" alt=\"Plus\">\n            <img decoding=\"async\" src=\"https:\/\/www.adocia.com\/composants\/themes\/adocia\/inc\/assets\/img\/icon-moins.png\" alt=\"Plus\">\n        <\/button>\n    <\/div>\n\n    <div class=\"content collapse\" id=\"item-5349\">\n        <div>\n            <div>\n\n                                    <p><b>Statut :<\/b> Phase 3 en Chine : r\u00e9sultats positifs sur le Diab\u00e8te de Type 1 et Type 2<br \/>\r\nPhase 3 aux Etats-Unis et en Europe pr\u00eate \u00e0 d\u00e9marrer sous r\u00e9serve de partenariat<\/p>\n                                                    <p><b>Partenariat :<\/b> Licenci\u00e9 \u00e0 Tonghua Dongbao en Chine et pour d'autres territoires en Asie. Disponible pour le reste du monde.<\/p>\n                                                    <p><b>Description du produit :<\/b> BioChaperone<sup>\u00ae<\/sup> Lispro (BC Lispro) est une nouvelle formulation d'insuline prandiale ultra-rapide contenant de l'insuline lispro et la technologie brevet\u00e9e BioChaperone<sup>\u00ae<\/sup> L'excipient BioChaperone<sup>\u00ae<\/sup> garantit une absorption plus rapide de l'insuline et permet une gestion plus efficace de la glyc\u00e9mie. <\/p>\n                                                    <p><b>Plateforme :<\/b> <span>BioChaperone<sup>\u00ae<\/sup><\/span><\/p>\n                                <div class=\"links\">\n                                            <a href=\"https:\/\/www.adocia.com\/fr\/medias-publications\/?_categories=medias&_products=5349\" class=\"theme-btn white\">\n                            M\u00e9dia<img decoding=\"async\" src=\"https:\/\/www.adocia.com\/composants\/themes\/adocia\/inc\/assets\/img\/icon-arrow_right_blue.svg\" alt=\"Arrow right\">\n                        <\/a>\n                                                                <a href=\"https:\/\/www.adocia.com\/fr\/products\/biochaperone-lispro\/\" class=\"theme-btn\">\n                            Voir plus<img decoding=\"async\" src=\"https:\/\/www.adocia.com\/composants\/themes\/adocia\/inc\/assets\/img\/icon-arrow_right.svg\" alt=\"Arrow right\">\n                        <\/a>\n                                    <\/div>\n            <\/div>\n        <\/div>\n\n    <\/div>\n\n\n<\/div>\n\n<div class=\"pipeline-item\">\n    <div class=\"first_level\">\n        <div class=\"infos\">\n            <h3 class=\"title\">BioChaperone<sup>\u00ae<\/sup> GLP-1 Amyline<\/h3>\n            <div class=\"sd\">\n                <span class=\"label\">Description :<\/span>\n                Combiner les produits de l'ob\u00e9sit\u00e9            <\/div>\n            <div class=\"i\">\n                <span class=\"label\">Indication :<\/span>\n                Ob\u00e9sit\u00e9            <\/div>\n        <\/div>\n        <div class=\"cell\"><span class=\"label active\">Pr\u00e9clinique<\/span><\/div>\n        <div class=\"cell\"><span class=\"label\">Phase 1<\/span><\/div>\n        <div class=\"cell\"><span class=\"label\">Phase 2<\/span><\/div>\n        <div class=\"cell\"><span class=\"label\">Phase 3<\/span><\/div>\n        <div class=\"cell\"><span class=\"label\">R\u00e9glementaire<\/span><\/div>\n        <div class=\"cell\"><span class=\"label\">Commercialisation<\/span><\/div>\n        <div class=\"bar\">\n            <svg version=\"1.1\" class=\"pipeline_img\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" x=\"0px\" y=\"0px\"\n                 viewBox=\"0 0 1950 50\" style=\"enable-background:new 0 0 1950 80;\" xml:space=\"preserve\">\n                <rect x=\"0\" y=\"0\" width=\"325\" height=\"100%\" rx=\"10\" ry=\"10\"><\/rect>\n            <\/svg>\n        <\/div>\n\n        <div class=\"partner\">\n                    <\/div>\n\n        <button type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#item-21053\" aria-expanded=\"false\" aria-controls=\"item-21053\">\n            <img decoding=\"async\" src=\"https:\/\/www.adocia.com\/composants\/themes\/adocia\/inc\/assets\/img\/icon-plus.png\" alt=\"Plus\">\n            <img decoding=\"async\" src=\"https:\/\/www.adocia.com\/composants\/themes\/adocia\/inc\/assets\/img\/icon-moins.png\" alt=\"Plus\">\n        <\/button>\n    <\/div>\n\n    <div class=\"content collapse\" id=\"item-21053\">\n        <div>\n            <div>\n\n                                    <p><b>Statut :<\/b> Formulation r\u00e9alis\u00e9e sur CagriSema (cagrilintide-semaglutide)<\/p>\n                                                                    <p><b>Description du produit :<\/b> BioChaperone\u00ae permet de stabiliser et co-formuler amyline et GLP-1 dans un seul et m\u00eame produit, et permet l\u2019utilisation de stylos multi-usages.<br \/>\r\n<\/p>\n                                                    <p><b>Plateforme :<\/b> <span>BioChaperone<sup>\u00ae<\/sup><\/span><\/p>\n                                <div class=\"links\">\n                                                                <a href=\"https:\/\/www.adocia.com\/fr\/products\/biochaperone-glp-1-amyline\/\" class=\"theme-btn\">\n                            Voir plus<img decoding=\"async\" src=\"https:\/\/www.adocia.com\/composants\/themes\/adocia\/inc\/assets\/img\/icon-arrow_right.svg\" alt=\"Arrow right\">\n                        <\/a>\n                                    <\/div>\n            <\/div>\n        <\/div>\n\n    <\/div>\n\n\n<\/div>\n\n<div class=\"pipeline-item\">\n    <div class=\"first_level\">\n        <div class=\"infos\">\n            <h3 class=\"title\">AdoXLong<sup>TM<\/sup> Sema<\/h3>\n            <div class=\"sd\">\n                <span class=\"label\">Description :<\/span>\n                GLP-1 longue dur\u00e9e d'action            <\/div>\n            <div class=\"i\">\n                <span class=\"label\">Indication :<\/span>\n                Obesit\u00e9            <\/div>\n        <\/div>\n        <div class=\"cell\"><span class=\"label active\">Pr\u00e9clinique<\/span><\/div>\n        <div class=\"cell\"><span class=\"label\">Phase 1<\/span><\/div>\n        <div class=\"cell\"><span class=\"label\">Phase 2<\/span><\/div>\n        <div class=\"cell\"><span class=\"label\">Phase 3<\/span><\/div>\n        <div class=\"cell\"><span class=\"label\">R\u00e9glementaire<\/span><\/div>\n        <div class=\"cell\"><span class=\"label\">Commercialisation<\/span><\/div>\n        <div class=\"bar\">\n            <svg version=\"1.1\" class=\"pipeline_img\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" x=\"0px\" y=\"0px\"\n                 viewBox=\"0 0 1950 50\" style=\"enable-background:new 0 0 1950 80;\" xml:space=\"preserve\">\n                <rect x=\"0\" y=\"0\" width=\"325\" height=\"100%\" rx=\"10\" ry=\"10\"><\/rect>\n            <\/svg>\n        <\/div>\n\n        <div class=\"partner\">\n                    <\/div>\n\n        <button type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#item-7174\" aria-expanded=\"false\" aria-controls=\"item-7174\">\n            <img decoding=\"async\" src=\"https:\/\/www.adocia.com\/composants\/themes\/adocia\/inc\/assets\/img\/icon-plus.png\" alt=\"Plus\">\n            <img decoding=\"async\" src=\"https:\/\/www.adocia.com\/composants\/themes\/adocia\/inc\/assets\/img\/icon-moins.png\" alt=\"Plus\">\n        <\/button>\n    <\/div>\n\n    <div class=\"content collapse\" id=\"item-7174\">\n        <div>\n            <div>\n\n                                    <p><b>Statut :<\/b> Preuve de concept pr\u00e9clinique obtenue<\/p>\n                                                                    <p><b>Description du produit :<\/b> AdoXLong Sema est une formulation de semaglutide \u00e0 action prolong\u00e9e, permettant de passer d\u2019une injection hebdomadaire \u00e0 une injection mensuelle. Des r\u00e9sultats pr\u00e9liminaires positifs in vitro et in vivo ont \u00e9t\u00e9 obtenus.<br \/>\r\n<\/p>\n                                                    <p><b>Plateforme :<\/b> <span>AdoXLong<sup>TM<\/sup><\/span><\/p>\n                                <div class=\"links\">\n                                                        <\/div>\n            <\/div>\n        <\/div>\n\n    <\/div>\n\n\n<\/div>\n\n<div class=\"pipeline-item\">\n    <div class=\"first_level\">\n        <div class=\"infos\">\n            <h3 class=\"title\">AdOral<sup>\u00ae<\/sup><br \/>\r\nSema<\/h3>\n            <div class=\"sd\">\n                <span class=\"label\">Description :<\/span>\n                Formulation Orale d\u2019un <span style=\"display: inline-block;\">GLP-1<\/span>            <\/div>\n            <div class=\"i\">\n                <span class=\"label\">Indication :<\/span>\n                Diab\u00e8te et Ob\u00e9sit\u00e9            <\/div>\n        <\/div>\n        <div class=\"cell\"><span class=\"label active\">Pr\u00e9clinique<\/span><\/div>\n        <div class=\"cell\"><span class=\"label\">Phase 1<\/span><\/div>\n        <div class=\"cell\"><span class=\"label\">Phase 2<\/span><\/div>\n        <div class=\"cell\"><span class=\"label\">Phase 3<\/span><\/div>\n        <div class=\"cell\"><span class=\"label\">R\u00e9glementaire<\/span><\/div>\n        <div class=\"cell\"><span class=\"label\">Commercialisation<\/span><\/div>\n        <div class=\"bar\">\n            <svg version=\"1.1\" class=\"pipeline_img\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" x=\"0px\" y=\"0px\"\n                 viewBox=\"0 0 1950 50\" style=\"enable-background:new 0 0 1950 80;\" xml:space=\"preserve\">\n                <rect x=\"0\" y=\"0\" width=\"325\" height=\"100%\" rx=\"10\" ry=\"10\"><\/rect>\n            <\/svg>\n        <\/div>\n\n        <div class=\"partner\">\n                    <\/div>\n\n        <button type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#item-5370\" aria-expanded=\"false\" aria-controls=\"item-5370\">\n            <img decoding=\"async\" src=\"https:\/\/www.adocia.com\/composants\/themes\/adocia\/inc\/assets\/img\/icon-plus.png\" alt=\"Plus\">\n            <img decoding=\"async\" src=\"https:\/\/www.adocia.com\/composants\/themes\/adocia\/inc\/assets\/img\/icon-moins.png\" alt=\"Plus\">\n        <\/button>\n    <\/div>\n\n    <div class=\"content collapse\" id=\"item-5370\">\n        <div>\n            <div>\n\n                                    <p><b>Statut :<\/b> Premier essai chez l\u2019Homme, sous r\u00e9serve de partenariat<\/p>\n                                                                    <p><b>Description du produit :<\/b> AdOral<sup>\u00ae<\/sup> Sema est un agoniste des r\u00e9cepteurs du glucagon-like peptide 1 (GLP1) administr\u00e9 par voie orale : le semaglutide. Adocia a appliqu\u00e9 sa technologie AdOral<sup>\u00ae<\/sup> pour changer la voie d'administration de cette mol\u00e9cule de la voie injectable \u00e0 la voie orale.<\/p>\n                                                    <p><b>Plateforme :<\/b> <span>AdOral<sup>\u00ae<\/sup><\/span><\/p>\n                                <div class=\"links\">\n                                                                <a href=\"https:\/\/www.adocia.com\/fr\/products\/adoral-sema\/\" class=\"theme-btn\">\n                            Voir plus<img decoding=\"async\" src=\"https:\/\/www.adocia.com\/composants\/themes\/adocia\/inc\/assets\/img\/icon-arrow_right.svg\" alt=\"Arrow right\">\n                        <\/a>\n                                    <\/div>\n            <\/div>\n        <\/div>\n\n    <\/div>\n\n\n<\/div>\n\n<div class=\"pipeline-item\">\n    <div class=\"first_level\">\n        <div class=\"infos\">\n            <h3 class=\"title\">AdoShell<sup>\u00ae<\/sup><br \/>\r\nIslets<\/h3>\n            <div class=\"sd\">\n                <span class=\"label\">Description :<\/span>\n                Matrice Immunoprotectrice pour la Th\u00e9rapie Cellulaire            <\/div>\n            <div class=\"i\">\n                <span class=\"label\">Indication :<\/span>\n                Diab\u00e8te            <\/div>\n        <\/div>\n        <div class=\"cell\"><span class=\"label active\">Pr\u00e9clinique<\/span><\/div>\n        <div class=\"cell\"><span class=\"label\">Phase 1<\/span><\/div>\n        <div class=\"cell\"><span class=\"label\">Phase 2<\/span><\/div>\n        <div class=\"cell\"><span class=\"label\">Phase 3<\/span><\/div>\n        <div class=\"cell\"><span class=\"label\">R\u00e9glementaire<\/span><\/div>\n        <div class=\"cell\"><span class=\"label\">Commercialisation<\/span><\/div>\n        <div class=\"bar\">\n            <svg version=\"1.1\" class=\"pipeline_img\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" x=\"0px\" y=\"0px\"\n                 viewBox=\"0 0 1950 50\" style=\"enable-background:new 0 0 1950 80;\" xml:space=\"preserve\">\n                <rect x=\"0\" y=\"0\" width=\"325\" height=\"100%\" rx=\"10\" ry=\"10\"><\/rect>\n            <\/svg>\n        <\/div>\n\n        <div class=\"partner\">\n                    <\/div>\n\n        <button type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#item-5360\" aria-expanded=\"false\" aria-controls=\"item-5360\">\n            <img decoding=\"async\" src=\"https:\/\/www.adocia.com\/composants\/themes\/adocia\/inc\/assets\/img\/icon-plus.png\" alt=\"Plus\">\n            <img decoding=\"async\" src=\"https:\/\/www.adocia.com\/composants\/themes\/adocia\/inc\/assets\/img\/icon-moins.png\" alt=\"Plus\">\n        <\/button>\n    <\/div>\n\n    <div class=\"content collapse\" id=\"item-5360\">\n        <div>\n            <div>\n\n                                    <p><b>Statut :<\/b> \u00celots humains: demande de premi\u00e8re \u00e9tude chez l\u2019homme en suspens<br \/>\r\nMaturation et efficacit\u00e9 d\u00e9montr\u00e9es in vivo avec des \u00eelots d\u00e9riv\u00e9s de cellules souches <\/p>\n                                                                    <p><b>Description du produit :<\/b> AdoShell<sup>\u00ae<\/sup> Islets est un implant \u00e0 base d'hydrogel contenant des \u00eelots de Langerhans ou des \u00eelots d\u00e9riv\u00e9s de cellules souches destin\u00e9 \u00e0 la th\u00e9rapie cellulaire du diab\u00e8te de type 1. Il vise \u00e0 am\u00e9liorer consid\u00e9rablement les protocoles de transplantation actuels en supprimant le besoin de traitements immunosuppresseurs et en rendant les \u00eelots implant\u00e9s r\u00e9cup\u00e9rables.<\/p>\n                                                    <p><b>Plateforme :<\/b> <span>AdoShell<sup>\u00ae<\/sup><\/span><\/p>\n                                <div class=\"links\">\n                                            <a href=\"https:\/\/www.adocia.com\/fr\/medias-publications\/?_categories=medias&_products=5360\" class=\"theme-btn white\">\n                            M\u00e9dia<img decoding=\"async\" src=\"https:\/\/www.adocia.com\/composants\/themes\/adocia\/inc\/assets\/img\/icon-arrow_right_blue.svg\" alt=\"Arrow right\">\n                        <\/a>\n                                                                <a href=\"https:\/\/www.adocia.com\/fr\/products\/adoshell-islets\/\" class=\"theme-btn\">\n                            Voir plus<img decoding=\"async\" src=\"https:\/\/www.adocia.com\/composants\/themes\/adocia\/inc\/assets\/img\/icon-arrow_right.svg\" alt=\"Arrow right\">\n                        <\/a>\n                                    <\/div>\n            <\/div>\n        <\/div>\n\n    <\/div>\n\n\n<\/div>\n\n<div class=\"pipeline-item\">\n    <div class=\"first_level\">\n        <div class=\"infos\">\n            <h3 class=\"title\">M1Pram<\/h3>\n            <div class=\"sd\">\n                <span class=\"label\">Description :<\/span>\n                Combinaison insuline-pramlintide            <\/div>\n            <div class=\"i\">\n                <span class=\"label\">Indication :<\/span>\n                Diab\u00e8te et Ob\u00e9sit\u00e9            <\/div>\n        <\/div>\n        <div class=\"cell\"><span class=\"label\">Pr\u00e9clinique<\/span><\/div>\n        <div class=\"cell\"><span class=\"label\">Phase 1<\/span><\/div>\n        <div class=\"cell\"><span class=\"label active\">Phase 2<\/span><\/div>\n        <div class=\"cell\"><span class=\"label\">Phase 3<\/span><\/div>\n        <div class=\"cell\"><span class=\"label\">R\u00e9glementaire<\/span><\/div>\n        <div class=\"cell\"><span class=\"label\">Commercialisation<\/span><\/div>\n        <div class=\"bar\">\n            <svg version=\"1.1\" class=\"pipeline_img\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" x=\"0px\" y=\"0px\"\n                 viewBox=\"0 0 1950 50\" style=\"enable-background:new 0 0 1950 80;\" xml:space=\"preserve\">\n                <rect x=\"0\" y=\"0\" width=\"812.5\" height=\"100%\" rx=\"10\" ry=\"10\"><\/rect>\n            <\/svg>\n        <\/div>\n\n        <div class=\"partner\">\n                            <ul>\n                                            <li>\n                            <img loading=\"lazy\" decoding=\"async\" width=\"250\" height=\"66\" src=\"https:\/\/www.adocia.com\/composants\/uploads\/2023\/05\/logo-sanofi.png\" class=\"attachment-full size-full\" alt=\"Sanofi\" \/>                        <\/li>\n                                    <\/ul>\n                    <\/div>\n\n        <button type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#item-5363\" aria-expanded=\"false\" aria-controls=\"item-5363\">\n            <img decoding=\"async\" src=\"https:\/\/www.adocia.com\/composants\/themes\/adocia\/inc\/assets\/img\/icon-plus.png\" alt=\"Plus\">\n            <img decoding=\"async\" src=\"https:\/\/www.adocia.com\/composants\/themes\/adocia\/inc\/assets\/img\/icon-moins.png\" alt=\"Plus\">\n        <\/button>\n    <\/div>\n\n    <div class=\"content collapse\" id=\"item-5363\">\n        <div>\n            <div>\n\n                                    <p><b>Statut :<\/b> Droits exclusifs de n\u00e9gociation d\u2019un partenariat mondial accord\u00e9s \u00e0 Sanofi sur les combinaisons insulin-pramlintide<\/p>\n                                                    <p><b>Partenariat :<\/b> Sanofi<\/p>\n                                                    <p><b>Description du produit :<\/b> M1Pram est une coformulation pr\u00eate \u00e0 l'emploi de pramlintide (un analogue de l'amyline) et de M1 (un analogue de l'insuline prandiale).<br \/>\r\nAdocia a d\u00e9velopp\u00e9 M1Pram pour permettre aux patients souffrant \u00e0 la fois de diab\u00e8te et de surpoids ou d'ob\u00e9sit\u00e9 d'aborder la gestion du poids et le contr\u00f4le de la glyc\u00e9mie comme des objectifs de soins communs.<\/p>\n                                                <div class=\"links\">\n                                            <a href=\"https:\/\/www.adocia.com\/fr\/medias-publications\/?_categories=medias&_products=5363\" class=\"theme-btn white\">\n                            M\u00e9dia<img decoding=\"async\" src=\"https:\/\/www.adocia.com\/composants\/themes\/adocia\/inc\/assets\/img\/icon-arrow_right_blue.svg\" alt=\"Arrow right\">\n                        <\/a>\n                                                                <a href=\"https:\/\/www.adocia.com\/fr\/products\/m1pram\/\" class=\"theme-btn\">\n                            Voir plus<img decoding=\"async\" src=\"https:\/\/www.adocia.com\/composants\/themes\/adocia\/inc\/assets\/img\/icon-arrow_right.svg\" alt=\"Arrow right\">\n                        <\/a>\n                                    <\/div>\n            <\/div>\n        <\/div>\n\n    <\/div>\n\n\n<\/div>\n            <\/div>\n        <\/div>\n    \n","protected":false},"excerpt":{"rendered":"[vc_row][vc_column][vc_column_text el_class=\"bg-grey p-4\"]M1Pram, une formulation unique d'analogues d'amyline et d'insuline qui a d\u00e9j\u00e0 fait ses preuves Adocia a d\u00e9velopp\u00e9 M1Pram pour permettre aux patients atteints [...]","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.adocia.com\/fr\/wp-json\/wp\/v2\/pages\/24754"}],"collection":[{"href":"https:\/\/www.adocia.com\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.adocia.com\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.adocia.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.adocia.com\/fr\/wp-json\/wp\/v2\/comments?post=24754"}],"version-history":[{"count":1,"href":"https:\/\/www.adocia.com\/fr\/wp-json\/wp\/v2\/pages\/24754\/revisions"}],"predecessor-version":[{"id":25178,"href":"https:\/\/www.adocia.com\/fr\/wp-json\/wp\/v2\/pages\/24754\/revisions\/25178"}],"wp:attachment":[{"href":"https:\/\/www.adocia.com\/fr\/wp-json\/wp\/v2\/media?parent=24754"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}